chrisvoncsefalvay/vaers-outcomes huggingface dataset:
dermatographia; heartburn; intense itchiness; tingling; itching of mouth and lips; itchy inner ear canal/ it "feels like anaphylaxis but its not, it is a immune response"; fully body hives; This spontaneous case was reported by a non-health professional and describes the occurrence of MECHANICAL URTICARIA (dermatographia), DYSPEPSIA (heartburn), PRURITUS (intense itchiness), PARAESTHESIA (tingling) and ORAL PRURITUS (itching of mouth and lips) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033F21A, 025B21A and 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DROSPIRENONE, ETHINYLESTRADIOL BETADEX CLATHRATE (YAZ), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, the patient experienced URTICARIA (fully body hives). On an unknown date, the patient experienced MECHANICAL URTICARIA (dermatographia), DYSPEPSIA (heartburn), PRURITUS (intense itchiness), PARAESTHESIA (tingling), ORAL PRURITUS (itching of mouth and lips) and EAR PRURITUS (itchy inner ear canal/ it "feels like anaphylaxis but its not, it is a immune response"). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, MECHANICAL URTICARIA (dermatographia), DYSPEPSIA (heartburn), PRURITUS (intense itchiness), PARAESTHESIA (tingling), ORAL PRURITUS (itching of mouth and lips) and EAR PRURITUS (itchy inner ear canal/ it "feels like anaphylaxis but its not, it is a immune response") outcome was unknown and URTICARIA (fully body hives) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Adderall 5mg (stopped due to suspected reaction), 4x recommended dose level of allergy OTC medications, 5 days of prednisone steroid.
A few days after the shot, I had a pain in my arm(at the injection site) and numbness and tingling in my hand.
All symptoms lasted for more than six days. There was redness, pain, itching, fever, chills, and the area temperature  was hot. at the end of the six days the skin shed in the area the length to my elbow.  Treatment was ice pad, heat pad Ibuprofen and Tylenol.
Vaccine given at 8:15 - throughout the morning tightness in chest developed - continued throughout the afternoon + itchiness developed. In the evening itchiness worsened + hives developed - cont. with chest tightness + developed coughing - took 50mg BENADRYL with relief. Still some what tight in chest today (next day) but able to work.
Developed  approximately  3 in by 3 in circular, red, raised rash on my right deltoid , right below the injection site. Red, itchy and warm. Slightly swollen.
Chills; feeling tired; feeling weak; it feels like he has a hangover; pain is mostly in his left shoulder; Pain upon movement; painful when he lifts his arm; soreness at the injection site; This case was reported by a consumer via call center representative and described the occurrence of chills in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th February 2020, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In February 2020, less than a day after receiving Shingrix, the patient experienced injection site pain, pain in arm, shoulder pain and pain upon movement. On 21st February 2020, the patient experienced chills, tiredness, feelings of weakness and hangover. On an unknown date, the outcome of the chills, injection site pain, tiredness, feelings of weakness and pain in arm were not recovered/not resolved and the outcome of the hangover, shoulder pain and pain upon movement were unknown.   It was unknown if the reporter considered the chills, injection site pain, tiredness, feelings of weakness, pain in arm, hangover, shoulder pain and pain upon movement to be related to Shingrix.  Additional details were provided as follows: On 20th February 2020, at 7:00 PM the patient received 2nd dose of Shingrix. On 21st February 2020, at morning, the patient began to experience soreness at the injection site and it was painful when he lifts his arm.  The pain was mostly in his left shoulder. The patient reported feeling tired, weak, and having chills and felt like hangover.  The patient given permission for his physician to be contacted. Unable to obtain additional details.
Redness, swelling, pain and itching of moderate intensity involving an area at injection site which was approximately 6x2 inches in size. The symptoms were severe enough to cause difficulty sleeping. They appeared in approximately 24 hrs after the injection, became more severe over days and resolved after approximately 10 days.
Inappropriate age at vaccine administration; Fever of 102.3 F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 102.3 F) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.   On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-May-2021, the patient experienced PYREXIA (Fever of 102.3 F). On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration). At the time of the report, PYREXIA (Fever of 102.3 F) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age at vaccine administration) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-May-2021, Body temperature: 102.3 (High) 102.3 F.         No treatment information was provided.   This case was linked to MOD-2021-193560 (Patient Link).
4:39 pm - Client complained "heaviness in neck region". There was no rash or tingling sensation.  Client was alert and oriented and left at 4:53 pm.
PATIENT CAME TO PHARAMCY TO RECEIVE HIS SECOND DOSE OF COVID VACCINE WHICH SHOULD BE MODERNA SINCE PATIENT RECIEVED MODERNA VACCINE AS FIRST DOSE, INSTEAD PATIENT WAS ADMINISTERED PFIZER VACCINE AS SECOND DOSE.
Pt. face flushed x 2 hours, no other R arm symptoms after receiving seasonal and L arm H1N1 injections, no sequelae.
Paresthesia, hand and foot tingling, sudden severe panic attacks, nausea, chest tightness, neck pain, headache, fatigue, dry cracked skin, fingernail abnormalities, weakness... All random and progressive. Continue to present. Facial and left arm parenthesis presented 2 months after first shot, then constant symptoms noted above after second shot. Third shot presented worsening of symptoms to present to include itchy skin, peeling skin, skin reactions, constant cold/flu like symptoms, night sweats, Reynaulds syndrome.
Upper left leg pain after vaccine; Shooting pain when standing up and walking around; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 13Apr2021 at 17:45 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medication was reported as birth control. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 21:00, the patient experienced upper left leg pain after vaccine and shooting pain when standing up and walking around. Therapeutic measures were not taken as a result of these events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events upper left leg pain after vaccine and shooting pain when standing up and walking around was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Two vaccines given in right arm, swollen and red half dollar size welts on deltoid and back of right arm.
The night of vaccination he had a fever and half of the arm is red, swollen, warm, and with some red spots, still at the third day of the vaccine.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 52-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05May2022 as dose 4 (booster), single (Lot number: fm9992) at the age of 52 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 30Dec2020 as dose 1, single (Lot number: 011j20a), on 29Jan2021 as dose 2, single (Lot number: 028l20a) and on 01Nov2021 as dose 3 (booster), single (Lot number: 071f21a) for covid-19 immunisation. The patient's relevant medical history included: "type 1 diabetes" (unspecified if ongoing), notes: type 1 diabetes; "hypothyroidism" (unspecified if ongoing); "known allergies: sulfa" (unspecified if ongoing), notes: known allergies: sulfa. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset Jul2022, outcome "unknown", COVID-19 (medically significant) with onset Jul2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (09Jul2022) negative; (10Jul2022) negative; (14Jul2022) positive, notes: antigen home test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Drug ineffective depends on many factors including pharmacokinetics, severity of disease and patient general health condition. However on conservative basis, the possible causality cannot be excluded.
Numbness and redness in cheeks day 1 of injection, Rash on cheeks and site of injection day 3 that is worsening with plaque like top that is sore and itches at border of rash
Initially she had only hurt in her arm; came down with shaking; she started having all of the pain in her upper stomach and her lower stomach that had escaladed; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 03Aug2021 as DOSE 1, SINGLE for covid-19 immunisation.  Medical history included surgery from Dec2020 to an unknown date she had surgery in DEC2020 that turned into a nightmare and it took her 3.5 months before making some progress, vaginal lesion from an unknown date and unknown if ongoing, precancerous lesion of digestive tract from an unknown date and unknown if ongoing, immunodeficiency from an unknown date and unknown if ongoing, hysterectomy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient previous received flu vaccine for influenza and pneumonia vaccine for pneumonia (STREPTOCOCCUS PNEUMONIAE) on unspecified date for immunisation. On 03Aug2021 the patient experienced initially she had only hurt in her arm, came down with shaking, she started having all of the pain in her upper stomach and her lower stomach that had escaladed.  The outcome of the events pain in extremity, tremor, abdominal pain upper was recovered.  Information on the lot/batch number has been requested.
Their computer had birthday wrong for this patient and received a booster dose from the Gray Cap; Their computer had birthday wrong for this patient and received a booster dose from the Gray Cap; fever; it was at least 100 but it might have been 101; had redness to his arm; warmness to arm/forearm; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A 10-year-old male patient received BNT162b2 (BNT162B2), on 04May2022 as dose 3 (booster), single (Lot number: FP4554, Expiration Date: 30Jun2022) at the age of 10 years, in left deltoid for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Two previous doses given of the Pfizer COVID-19 vaccine), for Covid-19 Immunization. The following information was reported: PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious), OVERDOSE (non-serious) all with onset 04May2022, outcome "unknown" and all described as "Their computer had birthday wrong for this patient and received a booster dose from the Gray Cap"; PYREXIA (non-serious) with onset May2022, outcome "unknown", described as "fever; it was at least 100 but it might have been 101"; ERYTHEMA (non-serious) with onset May2022, outcome "unknown", described as "had redness to his arm"; FEELING HOT (non-serious) with onset May2022, outcome "unknown", described as "warmness to arm/forearm". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia.  Additional information: 10 years old patient who had a 2 mistake inadvertent administration of the Pfizer COVID-19 Vaccine. Their computer had birthday wrong for this patient and received a booster dose from the Gray Cap.She says that the birthdate for the patient was put in as for a 16 year old. Caller says the patient had a fever this morning so he was left home from school, and his mother gave him Motrin, dosage unknown. She says she talked to the mother around 11:30AM, and he didn't have a fever or whatever. She says he also had redness to his arm and warmness to arm/forearm, but she feels like that is normal. The patient had no other conditions and had no other products.
Pt broke out into hives the night she recieved the vac. Pt was told she could take Benadryl for the itching.
Been to  hospital for asthma like breathing on 09/21/2021. Uncontrolable shackes and alot of joint pain. Have missed couple days of work.
Child was 11 months and receiving 6 months shots. Given on 10/06/2005 at 12:20pm. Father stated no problems with shots or medical problems. After shots left van. Parents with child returned at 2:05pm saying her eyes are itchy, right cheek flushed. Per annual report- And eyes watery.  Benadryl 12.5mg/5cc PO as per Emergency Protocol and child responding well.  Info given to mother and referred to ER. Did not go.  Called mother and child doing fine.
Patient here to receive booster after J&J 1st shot. Requested Moderna. Patient given .5ml of Moderna instead of .25ml. Due to miscommunication. No adverse reaction observed.
rash, dizziness, neck pain, hypertension, vomiting, mydriasis, diaphoresis: neck pain started within 10 mins, while other symptoms proceeded after about 20-30 mins.
Left thigh swelling & erythema  noted 9/9/2020. Next day erythema resolved and swelling better.
at 1:55pm  (approx 4 hours after the shot) all of a sudden my left arm at injection site hurt, my left forearm hurt, left upper back under shoulder blade  was painful. i had cold sweats, was dizzy and nauseous.  took tylenol. by 4pm felt much better.
10 months since my first shot; This case was reported by a consumer via media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date 10 months ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details provided were as follows: The case was reported by patient himself/herself. Age at vaccination was not applicable for this report. The patient received 1st dose 10 months ago and asked if it is too late to get the 2nd dose. Till the time of reporting, patient did not received 2nd dose which led to incomplete course of vaccination. Follow-up would not be possible as no contact details available.
W/n hour I was very lightheaded and dizzy. I was sporadically disoriented and extremely exhausted. From the following morning (Sunday) through Thursday of the same week I had severe back pain and pain and aches in my joints down my arms into my hands.  Dizziness also during that time period.
Left ear hurt; Neck hurt; Left arm hurt; Left fingers hurt; Sore throat; Burning sensation from her shoulder to her finger tips; Itchiness; Soreness of arm; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), BURNING SENSATION (Burning sensation from her shoulder to her finger tips), EAR PAIN (Left ear hurt), NECK PAIN (Neck hurt) and PAIN IN EXTREMITY (Left arm hurt; Left fingers hurt) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness) and VACCINATION SITE PAIN (Soreness of arm). On 07-Feb-2021, the patient experienced BURNING SENSATION (Burning sensation from her shoulder to her finger tips). On 08-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), EAR PAIN (Left ear hurt), NECK PAIN (Neck hurt) and PAIN IN EXTREMITY (Left arm hurt; Left fingers hurt). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), BURNING SENSATION (Burning sensation from her shoulder to her finger tips), EAR PAIN (Left ear hurt), NECK PAIN (Neck hurt), PAIN IN EXTREMITY (Left arm hurt; Left fingers hurt), VACCINATION SITE PRURITUS (Itchiness) and VACCINATION SITE PAIN (Soreness of arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Tylenol. No relevant concomitant medications were reported.
mom called w/ c/o high pitched crying for 3hrs following vax of DTP;advised 2nd dose of APAP to be given;pt stopped crying p/30mins was advised to call MD if crying resumed;
Had an apneic, seizure-like event with post-ictal phase - required PICU admission. Had an encephalopathic type course for 2d's with combativeness, unsteady gait; then full recovery.  10/15/2007 MR received for hospital DOS 8/23-26/2007 for D/C DX: Encephalopathy- resolved 2' to viral process or to DTaP vax. Child presented to the ER after an episode of fussiness, followed by gasping breaths, stiffening, and back arching with pallor.  Father gave a rescue breath which initiated breathing but child was not as responsive as usual.  Child had a mild runny nose x several days prior to incident.  Child continued to have recurring posturing and arching. Neuro consult for chief c/o Altered Mental Status, Seizures.
No adverse event; Patient received expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 62-year-old female patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine).        No concomitant medications were reported.    Order date and completion date was reported as 05-May-2022.  The vaccine from the vial with lot number O70H21A was administered to the patient in between a period of 08-Apr-2022 to 15-Dec-2022.  No treatment medications were reported.
Limited Range of Motion past 90 degrees overhead, pain 5/10  No swelling, redness, drainage, no fever
Patient presented with urine retention but also had a head cold. Patient is fully vaccinated and resulted positive.
This spontaneous report as received from a medical assistant refers to an unknown number of patients of unknown age and gender. No concurrent conditions, medical history or concomitant medications were reported. On an unknown date, the unknown number of patients were inadvertently vaccinated with M-M- R II LOT # K010319, expiration date 22-JUL-2015 (dose, strength, dose number, administration route were not reported), that had been improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
A. Two small raise area was notice after  the shot was given. B. Place cool compresses on arm.  C. Recommended to take benadryl but  client decline.  D. to visit Emergency clinic and Health care provider.
Felt fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Felt fatigue). At the time of the report, FATIGUE (Felt fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was unknown Treatment information was unknown.